作为大脑转移中的新的潜在生物标志物和治疗点的miRNAs
Ozal Beylerli1, Huaizhang Shi2, Sema Begliarzade3
1Central Research Laboratory, Bashkir State Medical University, Ufa, Republic of Bashkortostan, 3 Lenin Street, 450008, Russia.
Non-coding RNA research
|April 5, 2024
概括
非编码RNAs (ncRNAs),包括microRNAs (miRNAs),显示为诊断大脑转移的非侵入性生物标志物具有前途. 这些分子还提供了作为治疗点的潜力,以改善癌症患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物标志物 生物标志物
背景情况:
- 大脑转移是癌症死亡的主要原因,具有有限的非侵入性诊断选择.
- 诊断大脑转移的传统方法往往是不够的,需要新的方法.
研究的目的:
- 探索非编码RNAs (ncRNAs) 的潜力,特别是微RNAs (miRNAs) 和长非编码RNAs (lncRNAs),作为诊断生物标志物和大脑转移的治疗点.
- 研究ncRNAs在脑转移的免疫微环境中的作用及其对预后和治疗耐药性的影响.
主要方法:
- 对脑转移患者体液 (血清,脑脊液) 中的ncRNA表达特征的分析.
- 研究特定miRNAs在调控大脑免疫反应中的功能及其在将转移性与原发性瘤区分开来的潜力.
主要成果:
- 失调的ncRNAs在各种原发性癌症的大脑转移中被发现,这表明早期检测和干预的潜力.
- 在生物流体中进行ncRNA表达分析提供了一种非侵入性方法,以区分大脑转移和原发性瘤.
- 毫米RNA在大脑的免疫微环境中起着至关重要的作用,并且在诊断大脑转移和确定其起源方面表现有前途.
结论:
- 非编码RNAs,特别是miRNAs,代表了作为大脑转移的非侵入性诊断工具的重大进步.
- 操纵miRNAs具有治疗潜力,旨在降低治疗毒性并提高治疗大脑转移的有效性.
- 进一步临床验证ncRNAs对于完善诊断准确性和改善大脑转移的治疗策略至关重要.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K


